PAM71-HL Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

PAmAb is a fully human monoclonal antibody engineered to neutralize Bacillus anthracis protective antigen (PA), a key component of the anthrax toxin. It was developed to address the need for targeted therapies against inhalational anthrax, a severe and potentially lethal infection . Unlike earlier murine-derived antibodies, PAmAb minimizes immunogenic responses in humans, enhancing its therapeutic potential .

Structure

PAmAb conforms to the standard immunoglobulin structure:

  • Class: IgG1 (commonly used for its effector functions, such as Fc-mediated immune responses).

  • Subunits: Two light chains (κ or λ) and two heavy chains (γ), forming a Y-shaped molecule with antigen-binding F(ab) fragments and an Fc fragment for immune cell engagement .

  • Function: Binds specifically to PA, preventing its interaction with cellular receptors and thereby blocking toxin-mediated damage .

Therapeutic Applications

PAmAb demonstrates efficacy in preclinical models, including rabbit and monkey studies, where it significantly improved survival rates against inhalational anthrax . Its mechanism involves:

  • Neutralization: Directly blocking PA-receptor interactions.

  • Fc-mediated effects: Recruiting immune cells via Fc receptors to enhance clearance of PA-bound complexes .

Phase 1 Trial (2005)

A randomized, single-blind, placebo-controlled study evaluated PAmAb’s safety, pharmacokinetics, and bioavailability in 105 healthy volunteers . Key findings:

  • Safety: Well-tolerated with no severe adverse events.

  • Pharmacokinetics:

    ParameterValue
    Terminal half-life15–19 days
    Bioavailability (IM)50% (gluteus maximus), 71–85% (vastus lateralis)
    Dosing routesIntramuscular (IM) and intravenous (IV)
  • Biological activity: Serum concentrations correlated strongly with neutralization of PA in vitro .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PAM71-HL; At4g13590; T6G15.140; Protein PAM71-homolog, chloroplastic; GDT1-like protein 2; PHOTOSYNTHESIS AFFECTED MUTANT71-homolog
Target Names
PAM71-HL
Uniprot No.

Target Background

Function
This antibody targets PAM71-HL, a protein that is likely localized to the chloroplast and functions as a Mn(2+)/H(+) and/or Ca(2+)/H(+) antiporter. It plays a role in regulating Ca(2+), Mn(2+), and pH homeostasis within the chloroplast.
Database Links

KEGG: ath:AT4G13590

STRING: 3702.AT4G13590.1

UniGene: At.33360

Protein Families
GDT1 family
Subcellular Location
Plastid, chloroplast membrane; Multi-pass membrane protein.

Q&A

What is PAM71-HL Antibody and what protein does it target?

PAM71-HL Antibody is a research-grade immunoglobulin specifically designed to recognize and bind to the PAM71-HL protein. This protein is likely localized to the chloroplast and functions as a Mn(2+)/H(+) and/or Ca(2+)/H(+) antiporter. The antibody serves as a crucial tool for detecting, quantifying, and visualizing PAM71-HL protein in various experimental contexts including Western blotting, immunoprecipitation, and immunohistochemistry applications. Unlike other antibodies that may cross-react with similar proteins, properly validated PAM71-HL antibodies offer specificity for studying chloroplast ion transport mechanisms.

What is the cellular localization of the PAM71-HL protein?

Based on current research, PAM71-HL protein is primarily localized to the chloroplast membrane system. This localization is consistent with its proposed function as an ion antiporter involved in maintaining proper ion homeostasis within this photosynthetic organelle. The protein's presence in chloroplasts suggests its critical role in photosynthesis-related processes through the regulation of metal ion concentrations. Researchers can confirm this localization using subcellular fractionation techniques followed by immunoblotting with PAM71-HL antibodies or through confocal microscopy with fluorescently-labeled antibodies.

What are recommended storage conditions for PAM71-HL antibodies?

For optimal stability and performance, PAM71-HL antibodies should be stored according to manufacturer specifications, typically at -20°C for long-term storage or at 4°C for short-term use (1-2 weeks). Antibody solutions should contain appropriate preservatives (e.g., sodium azide at 0.02%) to prevent microbial contamination. Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and loss of antibody activity. Aliquoting the antibody into single-use volumes before freezing is recommended for research requiring multiple experiments over time.

How can PAM71-HL antibody be used to study chloroplast ion transport mechanisms?

PAM71-HL antibody provides several sophisticated approaches for investigating chloroplast ion transport:

  • Co-immunoprecipitation experiments to identify interaction partners of PAM71-HL within the chloroplast transport network

  • Immunolocalization to determine the precise sub-chloroplast membrane localization (thylakoid vs. envelope)

  • Quantitative immunoblotting to measure PAM71-HL protein levels under varying environmental conditions

  • Proteoliposome reconstitution assays where purified PAM71-HL is incorporated into artificial membranes for transport studies

  • In situ proximity ligation assays to identify protein-protein interactions in intact chloroplasts

These methodologies enable researchers to correlate PAM71-HL abundance and localization with functional transport activities, providing insights into how this antiporter contributes to chloroplast ion homeostasis.

What experimental approaches can be used to study the interaction between PAM71-HL and its ion substrates?

Multiple complementary techniques can characterize PAM71-HL interactions with Mn(2+) and Ca(2+):

  • Isothermal titration calorimetry (ITC) to measure binding affinities and thermodynamic parameters

  • Radioisotope flux assays using 45Ca(2+) or 54Mn(2+) to track ion movement across membranes

  • Fluorescence-based transport assays with ion-sensitive dyes in reconstituted proteoliposomes

  • Site-directed mutagenesis to identify critical amino acid residues for ion coordination

  • Electrophysiological techniques to measure ion currents when expressed in suitable systems

A typical experimental setup might include:

Experimental Condition[Mn²⁺] (μM)[Ca²⁺] (μM)pH gradient (ΔpH)Transport Rate (nmol/min/mg)
Control liposomes10002.00.8 ± 0.3
PAM71-HL liposomes10002.014.6 ± 1.7
PAM71-HL liposomes100001.2 ± 0.4
PAM71-HL liposomes1002002.08.3 ± 1.5
PAM71-HL liposomes01002.09.7 ± 1.6

These data would demonstrate the pH-dependent nature of transport and potential competition between ion substrates.

How does PAM71-HL function differ from other known chloroplast transporters?

PAM71-HL belongs to a specialized class of antiporters involved in divalent cation transport, distinguishing it from other chloroplast transporters:

  • While many chloroplast transporters focus on monovalent ions (K⁺, Na⁺), PAM71-HL specifically mediates divalent cation (Mn²⁺, Ca²⁺) exchange

  • Unlike photosynthetic electron transporters, PAM71-HL likely functions through a proton-coupled antiport mechanism

  • PAM71-HL may play a more specialized role in metal homeostasis compared to broader substrate range transporters

  • The protein likely contains unique structural features for selective binding of Mn²⁺ and Ca²⁺ ions

Understanding these functional differences requires comparative analysis using PAM71-HL antibodies alongside antibodies against other chloroplast transporters to correlate protein abundance with specific transport activities.

What controls should be included when using PAM71-HL antibodies in immunoblotting experiments?

Rigorous experimental design requires multiple controls:

  • Positive controls:

    • Recombinant PAM71-HL protein or overexpression samples

    • Wild-type tissue samples known to express PAM71-HL

  • Negative controls:

    • PAM71-HL knockout/knockdown plant lines

    • Pre-immune serum at equivalent concentration

    • Secondary antibody-only samples

  • Specificity controls:

    • Peptide competition assay (pre-incubating antibody with immunizing peptide)

    • Cross-absorption with related proteins

  • Technical controls:

    • Loading controls (e.g., actin, GAPDH)

    • Chloroplast-specific markers when working with organelle fractions

    • Molecular weight markers to confirm expected protein size

A systematic troubleshooting approach includes:

ObservationPossible CauseRecommended Solution
No signalInsufficient antibodyIncrease antibody concentration
Protein not expressedVerify expression with RT-PCR
Inefficient transferOptimize transfer conditions
Multiple bandsNon-specific bindingOptimize blocking and washing
Cross-reactivityPerform peptide competition
Protein degradationAdd protease inhibitors
Unexpected sizePost-translational modificationsTreat with phosphatases/glycosidases
Alternative splicingVerify with cDNA analysis

How can researchers optimize immunoprecipitation protocols for PAM71-HL in chloroplast membrane fractions?

Immunoprecipitation of membrane proteins like PAM71-HL requires specialized approaches:

  • Solubilization optimization:

    • Test multiple detergents (digitonin, n-dodecyl-β-D-maltoside, Triton X-100)

    • Determine optimal detergent concentrations (typically 0.5-2%)

    • Maintain detergent above critical micelle concentration throughout the procedure

  • Buffer optimization:

    • Include stabilizing agents (glycerol 10-20%)

    • Add protease inhibitors to prevent degradation

    • Maintain physiological pH (7.2-7.6)

  • Antibody coupling:

    • Direct coupling to magnetic beads improves recovery

    • Use oriented coupling chemistry to maximize antigen-binding capacity

    • Determine optimal antibody-to-bead ratio (typically 5-10 μg antibody per mg of beads)

  • Elution strategy:

    • Gentle elution with competing peptide preserves protein-protein interactions

    • Low pH elution (pH 2.5-3.0) maximizes recovery but may disrupt complexes

    • Direct elution in SDS sample buffer for maximum yield

A stepwise optimization approach typically yields significantly improved results compared to standard protocols designed for soluble proteins.

What are the recommended approaches for quantifying PAM71-HL protein levels in different plant tissues?

Accurate quantification requires careful consideration of tissue-specific factors:

  • Sample preparation:

    • Optimize extraction buffers for different tissue types

    • Include tissue-specific protease inhibitor combinations

    • Use standardized grinding methods for consistent extraction

  • Quantification methods:

    • Western blotting with fluorescent secondary antibodies for linear detection range

    • ELISA for high-throughput analysis across multiple samples

    • Multiple reaction monitoring (MRM) mass spectrometry for absolute quantification

  • Normalization strategies:

    • Use multiple reference proteins for robust normalization

    • Consider tissue-specific reference proteins rather than "universal" controls

    • Include spike-in standards for absolute quantification

  • Data analysis:

    • Apply appropriate statistical tests for tissue comparisons

    • Use technical and biological replicates (minimum n=3 for each)

    • Report variability measures (standard deviation, confidence intervals)

These approaches enable reliable comparison of PAM71-HL expression across different developmental stages, tissue types, and environmental conditions.

How should researchers interpret contradictory results between PAM71-HL protein levels and gene expression data?

Discrepancies between protein levels (detected by PAM71-HL antibodies) and gene expression offer valuable biological insights:

  • Post-transcriptional regulation:

    • miRNA-mediated repression may prevent translation despite high mRNA levels

    • RNA-binding proteins may alter mRNA stability or translation efficiency

    • Alternative splicing may create transcript variants with different translation properties

  • Post-translational regulation:

    • Differential protein stability under various conditions

    • Targeted protein degradation via the ubiquitin-proteasome system

    • Subcellular relocalization affecting extraction efficiency

  • Technical considerations:

    • Different detection limits between antibody-based methods and RT-qPCR

    • Sample preparation differences between protein and RNA analyses

    • Time-course differences in protein versus mRNA dynamics

A comprehensive approach includes:

Analysis MethodAdvantagesLimitationsApplication to PAM71-HL Research
RT-qPCRHigh sensitivityDoes not reflect protein levelsMeasure transcript abundance
Western blotDirect protein measurementSemi-quantitativeDetermine protein accumulation
Polysome profilingMeasures translation efficiencyLabor intensiveAssess translation status
Cycloheximide chaseMeasures protein stabilityAffects all proteinsDetermine protein turnover rate
Pulse-chase labelingTracks protein synthesis and degradationTechnically challengingMeasure synthesis and degradation rates

Integrating multiple analytical approaches provides the most complete understanding of PAM71-HL regulation.

What are the implications of post-translational modifications on PAM71-HL antibody detection?

Post-translational modifications (PTMs) can significantly affect antibody recognition:

  • Common PTMs affecting detection:

    • Phosphorylation may alter epitope accessibility

    • Glycosylation can block antibody binding sites

    • Proteolytic processing may remove epitopes

    • Ubiquitination can mask antibody binding sites

  • Experimental approaches to address PTM effects:

    • Use multiple antibodies targeting different epitopes

    • Perform immunoprecipitation followed by mass spectrometry to identify PTMs

    • Compare antibody detection before and after phosphatase/glycosidase treatment

    • Analyze protein under reducing and non-reducing conditions to assess disulfide effects

  • Interpretation strategies:

    • Multiple bands may represent different PTM states rather than non-specific binding

    • Absence of signal may indicate epitope modification rather than absence of protein

    • Tissue-specific differences in detection may reflect differential post-translational processing

Understanding PTM effects is crucial for accurate interpretation of PAM71-HL antibody data, particularly when comparing protein levels across different physiological conditions or tissue types.

How can researchers troubleshoot specificity issues with PAM71-HL antibodies in plant tissue immunolocalization studies?

Immunolocalization specificity challenges can be addressed systematically:

  • Antibody validation:

    • Test antibody on PAM71-HL knockout/knockdown tissues as negative controls

    • Perform peptide competition assays to confirm specificity

    • Use multiple antibodies targeting different epitopes for correlation

  • Protocol optimization:

    • Adjust fixation conditions to preserve epitope structure

    • Optimize antigen retrieval methods for membrane proteins

    • Test different permeabilization approaches to improve antibody access

  • Signal enhancement techniques:

    • Employ tyramide signal amplification for low-abundance targets

    • Use high-sensitivity detection systems (e.g., quantum dots, fluorescent nanobodies)

    • Implement structured illumination microscopy for improved resolution

  • Background reduction strategies:

    • Pre-absorb antibodies with plant tissue extracts from knockout lines

    • Use specific blocking agents to reduce non-specific binding

    • Implement automated image analysis for objective signal quantification

Systematic optimization can significantly improve specificity and signal-to-noise ratio in challenging tissue types.

What strategies can overcome cross-reactivity issues when using PAM71-HL antibodies?

Cross-reactivity challenges require comprehensive solutions:

  • Antibody purification approaches:

    • Affinity purification against the immunizing peptide

    • Negative selection against cross-reactive proteins

    • Subtractive adsorption using knockout tissue extracts

  • Experimental modifications:

    • Increasing stringency of washing conditions

    • Adjusting antibody concentration to minimize off-target binding

    • Using monoclonal antibodies with higher specificity when available

  • Validation techniques:

    • Parallel detection with alternative detection methods

    • Super-resolution microscopy to confirm expected subcellular localization

    • Multiple antibody approaches targeting different epitopes

  • Computational analysis:

    • Sequence comparison to identify potential cross-reactive proteins

    • Epitope mapping to identify unique regions for antibody generation

    • Image analysis algorithms to distinguish specific from non-specific signals

These strategies ensure reliable interpretation of PAM71-HL antibody data, particularly in complex tissue samples or experimental conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.